REGENXBIO Reports Update on Advancement of Programs for CLN2 Disease - read this article along with other careers information, tips and advice on BioSpace
Regenxbio (RGNX) Provides Update on RGX-181 and RGX-381 Programs streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced a comprehensive program update to outline its progress and development plans for RGX-181 and.